US2008306262A1PendingUtilityA1

Novel Compound

57
Assignee: ASTRAZENECA AB A SWEDISH CORPPriority: Sep 20, 2002Filed: Dec 27, 2007Published: Dec 11, 2008
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
Inventors:Roger Bonnert
A61P 37/02A61P 37/08A61P 43/00A61P 35/00A61P 29/00A61P 19/04A61P 19/02C07D 513/04A61P 11/16A61P 1/04A61P 17/06A61P 11/02A61P 19/10A61P 11/06A61P 11/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A compound of formula (I) and pharmaceutically acceptable salts or solvates thereof for use in therapy.

Claims

exact text as granted — not AI-modified
1 . A monosodium salt of the compound of formula (I): 
       
         
           
           
               
               
           
         
       
     
     
         2 . A process for the preparation of a compound of formula (I) of  claim 1 , which comprises reaction of a compound of formula (II): 
       
         
           
           
               
               
           
         
       
       where R is C 1-6  alkyl with an acid, 
       and thereafter forming a monosodium salt.

Join the waitlist — get patent alerts

Track US2008306262A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.